38
https://pubmed.ncbi.nlm.nih.gov/38115809
The study found that adding radiomics from multisite MRI to predictive models based on clinical and MRI parameters did not significantly improve the prediction of clinically significant prostate cancer in a multisite-multivendor setting.
